NANJING PANDA Shares Surge Over 3% Following Milestone in Traditional Chinese Medicine Brain-Computer Interface Equipment

Stock News
02/04

NANJING PANDA (00553) witnessed a notable surge exceeding 3% in its share price. As of the latest update, the stock had climbed 3.47% to HKD 5.37, with a trading turnover reaching HKD 34.56 million. The upward movement is attributed to recent developments. On February 4th, the Haihe Laboratory for Brain-Computer Interaction and Human-Machine Integration announced via its official WeChat account that a team led by Zhou Peng has innovatively developed an integrated technology combining "brain-computer interface with intelligent wearable acupuncture." This pioneering research has already secured backing from several preliminary projects, including a national manned spaceflight experiment initiative. The research team has dedicated years to advancing the modernization of Traditional Chinese Medicine techniques and their integration with cutting-edge technologies like brain-computer interfaces for equipment development. Previously, a collaborative effort between Tianjin University and Tianjin University of Traditional Chinese Medicine resulted in a "portable transcutaneous acupoint electrical stimulation device (space acupuncture)," which has been utilized in space-based experiments aboard multiple Shenzhou series manned spacecraft. Public information indicates that NANJING PANDA is strategically positioned in the low-earth orbit satellite communication terminal sector. Its next-generation terminals support direct "terminal-to-terminal" connections, bypassing the need for ground base stations, and are adaptable for use in mobile phones, vehicles, vessels, and aircraft. The company has partnered with StarThink Semiconductor, which specializes in integrated baseband chips for space-ground systems, enabling a terminal size reduction to one-fifth of traditional solutions and a 30% cut in power consumption. Significantly, the company secured new satellite-related orders approaching CNY 100 million in 2025.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10